Objective To determinate the accuracy and safety of implantation of the PORT-A-CATH®Fluoro Free®with CATH-FINDER® systemaidto determinate cathetertip position. Study Design The studyincluded32patients (15 males, 17 females) aged 51± 25 (mean ± s.d.) with malignantdiseaseneedinglong termintravenoustherapy. The CATH-FINDER® electroniccathetersensingdevicewasutilized to localize and position the central venous catheter tip.All patients underwent to post-operative chest x-ray and to a 2-weeks follow-up, to evaluate early complications. Results For the 32 portimplanted the operative time was 33,78± 5,39 minutes (mean ±s.d.). Allcathetertipswerepositionedaccurately(in the lower part of the superior vena cava) with CATH-FINDER® system, asconfirmed by chestradiography, performed 2 hours post implantation, and no patient required fluoroscopy. 20 ports(62,5%) wereplaced via the right subclavianvein, 5 (15,62%) via the leftsubclavianvein, 5 (15,62%) via the right innerjugularvein and 2 (6,25%) via the leftinnerjugularvein. No intraoperative or postoperative early complication wasdeveloped (suchasthrombophlebitis, hematoma, obstruction, pneumothorax,dislodgement or malposition of the central venous catheter). Discussion Implantation of the PORT-A-CATH® with the CATH-FINDER® system was performed easily, accurately and safely. The CATH-FINDER® system appears as an effective alternative to fluoroscopy peroperatively for accurate placement of catheter tip in the lower part of superior vena cava, by using the 3rd rib parasternally as external landmark. This determines a lower radiation exposure to staff and patients, and a significant reduction in cost placement.

FLUOROSCOPY-FREE CENTRAL VENOUS CATHETER PLACEMENT WITH CATH-FINDER® SYSTEM

FERRARO, Fausto
2013

Abstract

Objective To determinate the accuracy and safety of implantation of the PORT-A-CATH®Fluoro Free®with CATH-FINDER® systemaidto determinate cathetertip position. Study Design The studyincluded32patients (15 males, 17 females) aged 51± 25 (mean ± s.d.) with malignantdiseaseneedinglong termintravenoustherapy. The CATH-FINDER® electroniccathetersensingdevicewasutilized to localize and position the central venous catheter tip.All patients underwent to post-operative chest x-ray and to a 2-weeks follow-up, to evaluate early complications. Results For the 32 portimplanted the operative time was 33,78± 5,39 minutes (mean ±s.d.). Allcathetertipswerepositionedaccurately(in the lower part of the superior vena cava) with CATH-FINDER® system, asconfirmed by chestradiography, performed 2 hours post implantation, and no patient required fluoroscopy. 20 ports(62,5%) wereplaced via the right subclavianvein, 5 (15,62%) via the leftsubclavianvein, 5 (15,62%) via the right innerjugularvein and 2 (6,25%) via the leftinnerjugularvein. No intraoperative or postoperative early complication wasdeveloped (suchasthrombophlebitis, hematoma, obstruction, pneumothorax,dislodgement or malposition of the central venous catheter). Discussion Implantation of the PORT-A-CATH® with the CATH-FINDER® system was performed easily, accurately and safely. The CATH-FINDER® system appears as an effective alternative to fluoroscopy peroperatively for accurate placement of catheter tip in the lower part of superior vena cava, by using the 3rd rib parasternally as external landmark. This determines a lower radiation exposure to staff and patients, and a significant reduction in cost placement.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11591/207915
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact